Development of novel therapeutic strategy that targets pancreatic β cells for diabetes mellitus
2020-1012-06
- researcher's name
- affiliation
- research field
-
Pathological medical chemistry,General medical chemistry,Environmental physiology (including physical medicine and nutritional physiology)
- keyword
-
background
● Asians, especially Japanese, fail to evoke a compensatory hyperplasia of islets in Type II diabetes
● Treatment of type I diabetes with insulin is associated with a fatal risk of hypoglycemia
summary
● Increase in numbers of functional pancreatic β cells
● Creation of pancreatic β-like cells by transdifferentiation
predominance
● New drug that targets directly on pancreatic cells
● Realization of "curative" type I diabetes
● New therapeutic strategies for diabetes across types
application/development
● Medical industry
same researcher's seeds
posted:
2020/10/27
